Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Isodon inflexus extract is an ethanol or methanol extract prepared from the aerial parts of the plant Isodon inflexus, a member of the Lamiaceae family found in Korea, China, and Japan. It is traditionally used in folk medicine for treating gastrointestinal disorders, tumors, and inflammatory diseases. Modern research indicates the extract contains bioactive diterpenoids (including abietane and kaurane types as well as triterpenoids like ursolic acid), which exhibit pronounced anti-inflammatory and antioxidant activities. Its mechanism involves inhibition of nuclear factor kappa-B (NF-κB) and mitogen-activated protein kinase (MAPK) signaling pathways, leading to reduced expression of inflammatory cytokines, nitric oxide (NO) production, and improved histological and behavioral markers in inflammatory and atopic dermatitis animal models[1][3][4][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on isodon inflexus extract.